Wanbangde Pharmaceutical Holding Group Co., Ltd.
002082.SZ · SHZ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | CN¥3,933 | CN¥3,937 | CN¥5,409 | CN¥9,121 |
| - Cash | CN¥159 | CN¥227 | CN¥468 | CN¥912 |
| + Debt | CN¥970 | CN¥918 | CN¥863 | CN¥841 |
| Enterprise Value | CN¥4,744 | CN¥4,628 | CN¥5,804 | CN¥9,050 |
| Revenue | CN¥1,443 | CN¥1,542 | CN¥1,786 | CN¥1,931 |
| % Growth | -6.4% | -13.7% | -7.5% | – |
| Gross Profit | CN¥596 | CN¥624 | CN¥934 | CN¥931 |
| % Margin | 41.3% | 40.5% | 52.3% | 48.2% |
| EBITDA | CN¥170 | CN¥164 | CN¥337 | CN¥305 |
| % Margin | 11.8% | 10.6% | 18.9% | 15.8% |
| Net Income | CN¥55 | CN¥49 | CN¥93 | CN¥167 |
| % Margin | 3.8% | 3.2% | 5.2% | 8.6% |
| EPS Diluted | 0.091 | 0.08 | 0.152 | 0.27 |
| % Growth | 13.7% | -47.4% | -43.7% | – |
| Operating Cash Flow | CN¥120 | -CN¥73 | -CN¥240 | CN¥22 |
| Capital Expenditures | -CN¥88 | -CN¥129 | -CN¥167 | -CN¥277 |
| Free Cash Flow | CN¥32 | -CN¥202 | -CN¥407 | -CN¥255 |